KR890000089A - 신장 질환 치료제 - Google Patents

신장 질환 치료제 Download PDF

Info

Publication number
KR890000089A
KR890000089A KR1019880006895A KR880006895A KR890000089A KR 890000089 A KR890000089 A KR 890000089A KR 1019880006895 A KR1019880006895 A KR 1019880006895A KR 880006895 A KR880006895 A KR 880006895A KR 890000089 A KR890000089 A KR 890000089A
Authority
KR
South Korea
Prior art keywords
kidney disease
disease treatment
imidazolylmethyl
pharmaceutically acceptable
carboxylic acid
Prior art date
Application number
KR1019880006895A
Other languages
English (en)
Other versions
KR960007751B1 (ko
Inventor
히데미 마수무라
기요시 이리에
시니찌로 아시다
Original Assignee
수즈끼 다다시
다이이찌 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 수즈끼 다다시, 다이이찌 세이야꾸 가부시끼가이샤 filed Critical 수즈끼 다다시
Publication of KR890000089A publication Critical patent/KR890000089A/ko
Application granted granted Critical
Publication of KR960007751B1 publication Critical patent/KR960007751B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

신장 질환 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 6-(1-이미다졸릴메틸)-5,6,7,8-테트라하이드로-나프탈렌-2-카복실산 또는 그의 약제학적으로 허용되는 염을 활성 성분으로서 함유함을 특징으로 하는, 신장 질환의 예방 및 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880006895A 1987-06-10 1988-06-09 신장 질환 치료제 KR960007751B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14477987 1987-06-10
JP62-144779 1987-06-10
JP144779/87 1987-06-10

Publications (2)

Publication Number Publication Date
KR890000089A true KR890000089A (ko) 1989-03-11
KR960007751B1 KR960007751B1 (ko) 1996-06-12

Family

ID=15370238

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880006895A KR960007751B1 (ko) 1987-06-10 1988-06-09 신장 질환 치료제

Country Status (11)

Country Link
EP (1) EP0294814B1 (ko)
KR (1) KR960007751B1 (ko)
AT (1) ATE99933T1 (ko)
AU (1) AU609141B2 (ko)
CA (1) CA1310908C (ko)
DE (1) DE3887005T2 (ko)
DK (1) DK312888A (ko)
ES (1) ES2061563T3 (ko)
IL (1) IL86647A (ko)
PH (1) PH25092A (ko)
ZA (1) ZA884053B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative

Also Published As

Publication number Publication date
CA1310908C (en) 1992-12-01
IL86647A (en) 1992-02-16
DE3887005D1 (de) 1994-02-24
AU1753188A (en) 1988-12-15
EP0294814B1 (en) 1994-01-12
PH25092A (en) 1991-02-19
ATE99933T1 (de) 1994-01-15
KR960007751B1 (ko) 1996-06-12
ES2061563T3 (es) 1994-12-16
AU609141B2 (en) 1991-04-26
EP0294814A2 (en) 1988-12-14
DK312888A (da) 1988-12-11
DE3887005T2 (de) 1994-05-11
DK312888D0 (da) 1988-06-09
ZA884053B (en) 1989-02-22
IL86647A0 (en) 1988-11-30
EP0294814A3 (en) 1990-09-19

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
DE68902649D1 (de) Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen.
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
MX9203543A (es) Medicamento.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
DE69327328T2 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
KR930019224A (ko) 유산 위험 치료제
KR890000089A (ko) 신장 질환 치료제
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
ATE74505T1 (de) Schmerzpraeparat.
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee